📰 Interim Enrollment News
Interim Enrollment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Enrollment. Real-time updates on events, politics, business and more.
February 17, 2024
Interactive Chart for BAX240223P00036500 (BAX240223P00036500), analyze all the data with a huge range of indicators.
February 15, 2024
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing...
January 30, 2024
30.01.2024 - 85 patients enrolledTORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on ... Seite 1
January 30, 2024
Spectral Medical Inc. provided an update on the Companys Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated...
January 10, 2024
10.01.2024 - New patient enrollment sites accelerating screening activityScreening activity exceeding 100 patients per weekApproaching interim enrollment target of 90 patients TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) - Spectral Medical Inc. (“Spectral” or ... Seite 1
January 14, 2023
50 Patients Randomized to Date out of the 150 Total Target to be Enrolled Reports Significant Uptick in Screening and Enrollment Activities TORONTO, Jan....
January 12, 2023
Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments - read this article along with other careers information, tips and advice on BioSpace